SCHEMBL322456

SCHEMBL322456

CCc1nc2ccccc2s1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UBE2T Q9NPD8 1/20 0.66
ASIC3 Q9UHC3 1/20 0.66
RAB9A P51151 6/20 0.61
NPC1 O15118 5/20 0.61
MAPK1 P28482 2/20 0.61
GAA P10253 2/20 0.61
SMN1; SMN2 Q16637 6/20 0.56
L3MBTL1 Q9Y468 3/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2C19 P33261 1/20 0.56
MAPT P10636 5/20 0.54
PKM P14618 1/20 0.54
KDM4E B2RXH2 2/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
HTT P42858 2/20 0.51
LOXL2 Q9Y4K0 1/20 0.51
FBP1 P09467 1/20 0.51
ALOX15 P16050 1/20 0.51
PDE10A Q9Y233 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30626888 1.00 UBE2T (0.66) UBE2TASIC3RAB9ANPC1MAPK1
Bromide SCHEMBL3752068 0.98 UBE2T (0.63) UBE2TASIC3RAB9ANPC1MAPK1
Iodide SCHEMBL9450324 0.98 UBE2T (0.63) UBE2TASIC3RAB9ANPC1MAPK1
Perchlorate SCHEMBL5072706 0.89 UBE2T (0.54) UBE2TASIC3RAB9ANPC1MAPK1
Quinoline SCHEMBL28579596 0.87 ALDH1A1 (0.53) UBE2TASIC3RAB9ANPC1MAPK1
SCHEMBL12511 0.84 UBE2T (0.61) UBE2TASIC3RAB9ANPC1MAPK1
SCHEMBL19372016 0.83 UBE2T (0.70) UBE2TASIC3RAB9ANPC1MAPK1
SCHEMBL226465 0.83 UBE2T (0.70) UBE2TASIC3RAB9ANPC1MAPK1
Hydrogen Sulfide SCHEMBL23045115 0.82 UBE2T (0.59) UBE2TASIC3RAB9ANPC1MAPK1
Iodide SCHEMBL9106979 0.82 UBE2T (0.59) UBE2TASIC3RAB9ANPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 570 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119707859-A Para-substituted heptamethine quinone cyanine dye and synthetic method and application thereof 大连理工大学 2025-03-28 CN claimed
CN-113980583-A Ultraviolet curing composition glue based on pyridine substituted acrylate compound and using method and application thereof 西安思摩威新材料有限公司 2022-01-28 CN claimed
CN-113024483-A Preparation method of 2-substituted benzothiazole derivative 无锡鸣鹭医药科技有限公司 2021-06-25 CN claimed
CN-109233904-A A kind of oil refining apparatus high temperature corrosion inhibiting and descaling agent 浙江杭化科技股份有限公司 2019-01-18 CN claimed
CN-107987887-A A kind of oil refining apparatus increases income agent with high temperature inhibition 浙江杭化科技股份有限公司 2018-05-04 CN claimed
CN-102559263-B High temperature corrosion inhibitor for oil refining device ZHEJIANG HANGHUA TECHNOLOGY CO LTD 2014-03-12 CN claimed
EP-2493893-B1 AZABICYCLO[2.2.1]HEPTANE COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS BRISTOL MYERS SQUIBB CO (US) 2014-01-15 EP claimed
CN-102559263-A High temperature corrosion inhibitor for oil refining device ZHEJIANG HANGHUA TECHNOLOGY CO LTD 2012-07-11 CN claimed
US-4080493-A POLYBUTADIENE, POLYISOPRENE, GELATION INHIBITOR SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1978-03-21 US claimed
JP-63054366-A None JP disclosed
CN-119707859-A Para-substituted heptamethine quinone cyanine dye and synthetic method and application thereof 大连理工大学 2025-03-28 CN disclosed
US-20240417352-A1 EVOLVING RANDOM HETEROPOLYMERS TOWARDS CATALYTICALLY ACTIVE MATERIALS MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2024-12-19 US disclosed
US-20240309038-A1 NOVEL GALACTOSIDE INHIBITOR OF GALECTINS GALECTO BIOTECH AB (DK) 2024-09-19 US disclosed
US-20240294821-A1 CORROSION INHIBITION COMPOSITIONS AND METHODS OF USE IN SOUR ENVIRONMENTS SAUDI ARABIAN OIL COMPANY (SA) 2024-09-05 US disclosed
US-4289766-A Heterocyclic carbothioamides ELI LILLY AND COMPANY (US) 1981-09-15 US disclosed
US-4161571-A GELATION INHIBITORS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1979-07-17 US disclosed
EP-0002938-A2 Novel heterocyclic carbothioamides, compositions containing them, their preparation and use ELI LILLY AND COMPANY (US) 1979-07-11 EP disclosed
US-4097484-A ORGANIC PIGMENTS, PLASTICS CIBA-GEIGY CORPORATION (US) 1978-06-27 US disclosed
US-4080493-A POLYBUTADIENE, POLYISOPRENE, GELATION INHIBITOR SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1978-03-21 US disclosed
US-4002635-A FOR COLORING PLASTICS AND LACQUERS CIBA-GEIGY CORPORATION (US) 1977-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240309038-A1 NOVEL GALACTOSIDE INHIBITOR OF GALECTINS LGALS3, LGALS1, LGALS3BP UBE2T 3845/4885ASIC3 3339/4885RAB9A 2560/4885
US-20240417352-A1 EVOLVING RANDOM HETEROPOLYMERS TOWARDS CATALYTICALLY ACTIVE MATERIALS PNKP, MGAM, HMBS UBE2T 2754/4885ASIC3 4119/4885RAB9A 4162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.